Ultrasound-guided Peripheral Intravenous Catheter Placement in an Oncologic Emergency Department - a Prospective, Randomized Controlled Trial of Catheter Lengths
For patients and families
In plain language
An automatic summary of structured registry data. It is an orientation aid, not a substitute for the official protocol or a physician assessment.
- What is being studied
- The protocol lists: Introcan Safety IV Catheter.
- Who it may be relevant to
- Registry conditions: Oncologic Complications and Emergencies. Basic parameters: from 18 years · All.
- What needs checking
- Age, condition and sex are only basic indicators. Prior treatment, laboratory values and other mandatory requirements appear in the eligibility criteria below.
- Where it takes place
- United States
- Next step
- Save the trial, show it to the treating physician, and confirm current recruitment with the study center. Costs, documents and travel →
Unsure about the terms? Read our patient guide →
Overview
To learn about the effects of the length of the catheter on the failure and success rate of USIV placement.
Detailed description
Primary Objectives:
\- The rate of catheter failure, defined as removal of the catheter for any reason other than "Care Complete" (i.e. a composite of removal due to "infiltration," "leaking," "catheter damage," "occlusion"), by day 10.
Secondary Objectives:
1. Time from catheter placement to removal (i.e. survival or dwell time). 2. Per catheter length rate of failure analysis 3. Rate of repeat catheterization 4. Rate of infection 5. Rate of thrombosis
Interventions
- Device Introcan Safety IV Catheter
Given by IV
Primary outcome measures
- Safety and adverse events (AEs) [Time frame: Through study completion; an average of 1 year.]
Eligibility criteria
Inclusion criteria
- Age > 18 years old.
- Provision of signed and dated informed consent form.
- Predetermined to have difficult IV access necessitating USIV placement
- Expected admission to hospital with anticipated stay > 48 hours (per discussion with treating physician).
Exclusion criteria
- Expected/anticipated discharge disposition from the ACCC (per discussion with treating physician).
- Inability to give informed consent.
- Pregnant women.
- Non-English speaking participants.
Criteria are shown verbatim from the registry (in English). Final eligibility is always assessed by the study center.
Healthy volunteers: No
Study design
- Allocation
- Randomized
- Model
- Parallel assignment
- Masking
- Open label
- Primary purpose
- Prevention
Study locations
United States · 1 center
- MD Anderson Cancer Center — Houston
Identifiers
NCT: NCT06217783 · 2023-0848 · NCI-2024-00503